Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu

Castro, Júlia T.; Caldas, Gabriela de Assis Burle; Gonçalves, Ana Paula de Faria; Doro, Daniel; Cardoso, Kimberly Freitas; Teixeira, Santuza Maria Ribeiro; Machado, Alexandre de Magalhães Vieira; Gazzinelli, Ricardo Tostes.
No convencional en Inglés | ARCA | ID: arc-46734

Documentos relacionados

  1. SARS-CoV-2 and influenza virus co-infection.
  2. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
  3. Molecular Architecture of the SARS-CoV-2 Virus.
  4. A perspective on potential antibody-dependent enhancement of SARS-CoV-2.
  5. Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear.
  6. COVID-19 Makes B Cells Forget, but T Cells Remember.
  7. Abrupt Subsidence of Seasonal Influenza after COVID-19 Outbreak, Hong Kong, China.
  8. SnapShot: COVID-19.
  9. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
  10. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks.